$AKOM
Aerkomm Inc. Stock $akom

$akom Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024047257 Filed on May 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$53.26K	$223.1K
YoY Change	-88.28%	-3776.11%
Cost Of Revenue	$38.12K	$1.339M
YoY Change	-91.49%
Gross Profit	$15.14K	-$1.116M
YoY Change	132.91%	18279.24%
Gross Profit Margin	28.43%	-499.96%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$11.28K	$36.71K
YoY Change		-93.08%
% of Gross Profit	74.51%
Depreciation & Amortization	$34.00K	$1.367M
YoY Change	-81.28%	369.15%
% of Gross Profit	224.59%
Operating Expenses	$5.066M	$4.253M
YoY Change	39.06%	-2.22%
Operating Profit	-$5.051M	-$5.368M
YoY Change	38.89%	23.25%
Interest Expense	-$1.529M	$982.9K
YoY Change	2447.93%	-0.33%
% of Operating Profit
Other Income/Expense, Net	6.820M jpies	-$582.6K
YoY Change	-5903.76%	155.88%
Pretax Income	-$6.593M	-$9.529M
YoY Change	75.6%	233.55%
Income Tax	$2.400K	$0.00
% Of Pretax Income
Net Earnings	-$6.595M	-$9.529M
YoY Change	75.66%	233.4%
Net Earnings / Revenue	-12384.04%	-4270.23%
Basic Earnings Per Share	-$0.37
Diluted Earnings Per Share	-$0.37	-$0.56
COMMON SHARES
Basic Shares Outstanding	16.87M shares	9.869M shares
Diluted Shares Outstanding	17.84M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.753M	$8.008M
YoY Change	-13.12%	-9.9%
Cash & Equivalents	$118.8K	$7.429M
Short-Term Investments	$3.649M	$3.805M
Other Short-Term Assets	$66.78K	$65.94K
YoY Change	-87.41%	-99.18%
Inventory	$170.9K	$170.9K
Prepaid Expenses	$199.1K	$158.2K
Receivables	$0.00	$41.09K
Other Receivables	$293.2K	$122.0K
Total Short-Term Assets	$6.004M	$9.734M
YoY Change	-57.31%	-48.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.40M	$42.79M
YoY Change	9.72%	13.13%
Goodwill	$4.574M	$4.574M
YoY Change	0.28%	0.28%
Intangibles	$12.58M	$13.02M
YoY Change	883.5%	828.68%
Long-Term Investments	$4.087M	$4.262M
YoY Change	-4.51%	-6.79%
Other Assets	$2.620M	$5.837M
YoY Change	-54.76%	-28.04%
Total Long-Term Assets	$73.92M	$79.03M
YoY Change	37.62%	52.28%
TOTAL ASSETS
Total Short-Term Assets	$6.004M	$9.734M
Total Long-Term Assets	$73.92M	$79.03M
Total Assets	$79.92M	$88.77M
YoY Change	17.92%	25.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.898M	$1.900M
YoY Change	18.82%	-2.59%
Accrued Expenses	$8.552M	$18.77M
YoY Change	-8.54%	634.97%
Deferred Revenue
YoY Change
Short-Term Debt	$164.7K	$132.3K
YoY Change	-92.06%	-89.95%
Long-Term Debt Due	$2.720M	$5.045K
YoY Change	23266.23%	-77.2%
Total Short-Term Liabilities	$33.86M	$28.08M
YoY Change	159.48%	125.38%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$100.3K	$120.9K
YoY Change	-86.97%	-84.61%
Total Long-Term Liabilities	$24.24M	$33.71M
YoY Change	-27.05%	1.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.86M	$28.08M
Total Long-Term Liabilities	$24.24M	$33.71M
Total Liabilities	$58.09M	$61.79M
YoY Change	25.55%	35.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$81.32M	-$74.72M
YoY Change	41.66%	39.28%
Common Stock	$17.81K	$16.72K
YoY Change	83.26%	72.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.83M	$26.98M
YoY Change
Total Liabilities & Shareholders Equity	$79.92M	$88.77M
YoY Change	17.92%	25.66%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$6.595M	-$9.529M
YoY Change	75.66%	233.4%
Depreciation, Depletion And Amortization	$34.00K	$1.367M
YoY Change	-81.28%	369.15%
Cash From Operating Activities	-$2.473M	$7.895M
YoY Change	-51.62%	-312.55%
INVESTING ACTIVITIES
Capital Expenditures	$357.4K	$5.951M
YoY Change	5.1%	359.52%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$357.3K	-$5.951M
YoY Change	3387.31%	342.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$3.086K
YoY Change	18.46%
Cash From Financing Activities	-$5.749M	4.065M
YoY Change	-863.64%	-59.39%
NET CHANGE
Cash From Operating Activities	-$2.473M	7.895M
Cash From Investing Activities	-$357.3K	-5.951M
Cash From Financing Activities	-$5.749M	4.065M
Net Change In Cash	-$8.579M	6.009M
YoY Change	96.4%	21.3%
FREE CASH FLOW
Cash From Operating Activities	-$2.473M	$7.895M
Capital Expenditures	$357.4K	$5.951M
Free Cash Flow	-$2.830M	$1.944M
YoY Change	-48.08%	-138.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	akom	Purchase From Ejectt PurchaseFromEjectt	53255	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1279688	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	10.8161
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.3194
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	805103	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.5605
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.9779
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2084791	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.6279
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.2566
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2084791	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.6279
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.2566
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	11000	shares
CY2022Q4	akom	Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.507
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	805103	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.9779
CY2023	akom	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesVested	-144426	shares
CY2023	akom	Average Granted Date Fair Value Vestedin Dollars Per Share AverageGrantedDateFairValueVestedinDollarsPerShare	2.1351
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	671677	shares
CY2023Q4	akom	Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.9691
CY2024Q1	akom	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Vested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesVested	-49147	shares
CY2024Q1	akom	Average Granted Date Fair Value Vestedin Dollars Per Share AverageGrantedDateFairValueVestedinDollarsPerShare	1.9691
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	622530	shares
CY2024Q1	akom	Sharebased Compensations Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.9691
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	2.58
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	2.89
CY2018Q2	us-gaap	Professional Fees ProfessionalFees	1200000	usd
CY2020Q4	akom	Refund Payment Amount RefundPaymentAmount	8000000	usd
CY2020Q4	us-gaap	Payments For Fees PaymentsForFees	190000	usd
CY2022Q4	us-gaap	Option Indexed To Issuers Equity Settlement Alternatives Shares At Fair Value OptionIndexedToIssuersEquitySettlementAlternativesSharesAtFairValue	25500000	shares
CY2024Q1	us-gaap	Investments Investments	15000000	usd
CY2024Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	11.5
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	akom	Subscribed Capital SubscribedCapital		usd
CY2023Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-55925
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	AERKOMM INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3424568
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	44043 Fremont Blvd
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2024Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
CY2024Q1	dei	City Area Code CityAreaCode	(877)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	742-3094
CY2024Q1	dei	Security12b Title Security12bTitle	None
CY2024Q1	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17962613	shares
CY2024Q1	us-gaap	Cash Cash	103756	usd
CY2023Q4	us-gaap	Cash Cash	4202797	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	3649315	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	3804850	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	41088	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	170892	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	170892	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	199050	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	158171	usd
CY2024Q1	akom	Other Receivable Related Parties OtherReceivableRelatedParties	1520862	usd
CY2023Q4	akom	Other Receivable Related Parties OtherReceivableRelatedParties	1167749	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	293198	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	122024	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	66779	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	65937	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6003852	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9733508	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	4087065	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	4261920	usd
CY2024Q1	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	5410830	usd
CY2023Q4	akom	Property Plant And Equipment Cost PropertyPlantAndEquipmentCost	5436657	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3145708	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3085789	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2265122	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2350868	usd
CY2024Q1	us-gaap	Land Land	38814576	usd
CY2023Q4	us-gaap	Land Land	40114286	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	322812	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	324866	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41402510	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	42790020	usd
CY2024Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	10539370	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	10402155	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	15019	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	3225905	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12576483	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13024692	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4573819	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4573819	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	191307	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	221417	usd
CY2024Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	531097	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	534515	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	28427095	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	31982503	usd
CY2024Q1	us-gaap	Assets Assets	79920522	usd
CY2023Q4	us-gaap	Assets Assets	88767951	usd
CY2024Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	164671	usd
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	132257	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1897820	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1900317	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	8390567	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	5995972	usd
CY2024Q1	akom	Other Payable Related Parties OtherPayableRelatedParties	741842	usd
CY2023Q4	akom	Other Payable Related Parties OtherPayableRelatedParties	726802	usd
CY2024Q1	akom	Other Payable Current OtherPayableCurrent	13616753	usd
CY2023Q4	akom	Other Payable Current OtherPayableCurrent	12617277	usd
CY2024Q1	akom	Prepayment From Customer Related Party PrepaymentFromCustomerRelatedParty	6154989	usd
CY2023Q4	akom	Prepayment From Customer Related Party PrepaymentFromCustomerRelatedParty	6534908	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2720296	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5045	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	170500	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	168433	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	33857438	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28081011	usd
CY2024Q1	us-gaap	Long Term Transition Bond LongTermTransitionBond	200000	usd
CY2023Q4	us-gaap	Long Term Transition Bond LongTermTransitionBond	9648155	usd
CY2024Q1	akom	Convertible Longterm Note Payable ConvertibleLongtermNotePayable	23173200	usd
CY2023Q4	akom	Convertible Longterm Note Payable ConvertibleLongtermNotePayable	23173200	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	762000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	762000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	100329	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	120932	usd
CY2024Q1	akom	Restricted Stock Deposit Liability RestrictedStockDepositLiability	1000	usd
CY2023Q4	akom	Restricted Stock Deposit Liability RestrictedStockDepositLiability	1000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	24236529	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	33705287	usd
CY2024Q1	us-gaap	Liabilities Liabilities	58093967	usd
CY2023Q4	us-gaap	Liabilities Liabilities	61786298	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17813451	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17813451	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17813451	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17813451	shares
CY2024Q1	akom	Restricted Stock Shares RestrictedStockShares	149162	shares
CY2023Q4	akom	Restricted Stock Shares RestrictedStockShares	149162	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	17813	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	16720	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	104205425	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97015470	usd
CY2023Q4	akom	Subscribed Capital SubscribedCapital	5004000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81315073	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74719954	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1081610	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-334583	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	21826555	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26981653	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79920522	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88767951	usd
CY2024Q1	us-gaap	Revenues Revenues	53255	usd
CY2023Q1	us-gaap	Revenues Revenues	454281	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	38116	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	447781	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	15139	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	6500	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5066442	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3643426	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5051303	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3636926	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-688595	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	179589	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	672	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7829	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	840837	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	361207	usd
CY2024Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-12656	usd
CY2023Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	71937	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1541416	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-117510	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6592719	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3754436	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6595119	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3754436	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-747027	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	134254	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7342146	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3620182	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.3697
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.3804
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.3697
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.3804
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17839228	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9869165	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17839228	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9869165	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25067770	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	54891	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	134254	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3754436	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	21502479	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26981653	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1554000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	633048	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-747027	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6595119	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	21826555	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-6595119	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3754436	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	506980	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	316272	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	633048	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54891	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	672	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7829	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	216942	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	125135	usd
CY2024Q1	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	383239	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-41088	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	703222	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2138165	usd
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-3418	usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	6236	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2497	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-353703	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3029865	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	655362	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	14401	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-17880	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2472529	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5110931	usd
CY2024Q1	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	346070	usd
CY2023Q1	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-325578	usd
CY2024Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	11275	usd
CY2023Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	335825	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-357345	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10247	usd
CY2024Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	32414	usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	758439	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3086	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2605	usd
CY2024Q1	akom	Prepayment For Land PrepaymentForLand	5004000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6558000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7330000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2826	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2924	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5749498	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	752910	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8579372	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4368268	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7428702	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10101920	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1269445	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-210105	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118775	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5523547	usd
CY2024Q1	us-gaap	Cash Cash	103756	usd
CY2023Q1	us-gaap	Cash Cash	2299190	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	15019	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	3224357	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118775	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5523547	usd
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.863	pure
CY2017Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.997	pure
CY2022Q4	akom	Majority Interest MajorityInterest	25500000	shares
CY2022Q4	akom	Taiwan Buyer TaiwanBuyer	255000000	twd
CY2022	akom	Taiwan Buyer TaiwanBuyer	8300000	usd
CY2024Q1	us-gaap	Bridge Loan BridgeLoan	10000000	usd
CY2024Q1	akom	Aggregate Principal Amount aggregatePrincipalAmount	20000000	usd
CY2024Q1	akom	Principal Loan Percentage PrincipalLoanPercentage	0.25	pure
CY2024Q1	akom	Working Capital WorkingCapital	20000000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Reclassifications of Prior Year Presentation </span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year balance sheet, and cash flow statement amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates.</span></p>
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Concentrations of Credit Risk</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash in banks. As of March 31, 2024 and December 31, 2023, the total balance of cash in bank exceeding the amount insured by the Federal Deposit Insurance Corporation (FDIC) for the Company was approximately $0 and $0, respectively. The balance of cash deposited in foreign financial institutions exceeding the amount insured by local insurance is approximately $94,000 and $7,246,000 as of March 31, 2024 and December 31, 2023, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company performs ongoing credit evaluation of its customers and requires no collateral. An allowance for doubtful accounts is provided based on a review of the collectability of accounts receivable. The Company determines the amount of allowance for doubtful accounts by examining its historical collection experience and current trends in the credit quality of its customers as well as its internal credit policies. Actual credit losses may differ from management’s estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	usd
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2023Q1	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse		usd
CY2024Q1	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments		usd
CY2023Q1	akom	Prepayment For Land PrepaymentForLand		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2024Q1	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	0	usd
CY2023	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	41088	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	akom	Investment Cost Ana Navi Tek InvestmentCostAnaNaviTek		usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2024Q1	akom	Goodwill Addition GoodwillAddition		usd
CY2024Q1	akom	Accumulated Impairment Addition AccumulatedImpairmentAddition		usd
CY2024Q1	akom	Goodwill Addition Net GoodwillAdditionNet		usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths		usd
CY2024Q1	us-gaap	Net Investment In Lease Noncurrent NetInvestmentInLeaseNoncurrent		usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths		usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo		usd
CY2024Q1	akom	Translationadjustmentspolicytextblock Translationadjustmentspolicytextblock	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Translation Adjustments</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a foreign subsidiary’s functional currency is the local currency, translation adjustments will result from the process of translating the subsidiary’s financial statements into the reporting currency of the Company. Such adjustments are accumulated and reported under other comprehensive loss as a separate component of stockholders’ equity.</span></p>
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6500900	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2011867	shares
CY2019Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	225500	usd
CY2019Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	200000	eur
CY2019Q3	akom	Dividends Shares Based Compensation Cash DividendsSharesBasedCompensationCash	20000	eur
CY2024Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	13831	usd
CY2024Q1	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	672	usd
CY2020Q4	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	6000000	shares
CY2020Q4	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	5027600	usd
CY2022Q3	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	35000000	twd
CY2024Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	1096148	usd
CY2023Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	1143044	usd
CY2024Q1	akom	Investment Ejectt Shortterm InvestmentEjecttShortterm	2539336	usd
CY2023Q4	akom	Investment Ejectt Shortterm InvestmentEjecttShortterm	2647975	usd
CY2024Q1	akom	Investment Liquidity InvestmentLiquidity	13831	usd
CY2023Q4	akom	Investment Liquidity InvestmentLiquidity	13831	usd
CY2024Q1	us-gaap	Prepaid Interest PrepaidInterest	1096148	usd
CY2023Q4	us-gaap	Prepaid Interest PrepaidInterest	1143044	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	3649315	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	3804850	usd
CY2024Q1	akom	Appreciation In Market Value AppreciationInMarketValue	1935933	usd
CY2023Q4	akom	Appreciation In Market Value AppreciationInMarketValue	2018757	usd
CY2024Q1	akom	Investment Cost Ejectt Shortterm InvestmentCostEjecttShortterm	603403	usd
CY2023Q4	akom	Investment Cost Ejectt Shortterm InvestmentCostEjecttShortterm	629218	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	13831	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	13831	usd
CY2024Q1	akom	Prepaid Investment Cost PrepaidInvestmentCost	1096148	usd
CY2023Q4	akom	Prepaid Investment Cost PrepaidInvestmentCost	1143044	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	170892	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	170892	usd
CY2024Q1	akom	Prepaid Professional Expense PrepaidProfessionalExpense	118854	usd
CY2023Q4	akom	Prepaid Professional Expense PrepaidProfessionalExpense	110043	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	80196	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	48128	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	199050	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	158171	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	2073448	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	2076138	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8465922	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8326017	usd
CY2024Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	10539370	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	10402155	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2024Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	akom	Refundable Prepayments RefundablePrepayments	1098549407	twd
CY2024Q1	akom	Refundable Prepayments RefundablePrepayments	34404930	usd
CY2023Q4	akom	Refundable Prepayments RefundablePrepayments	35876858	usd
CY2024Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	42251900	twd
CY2024Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	1323267	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	1379879	usd
CY2024Q1	us-gaap	Depreciation Depreciation	72051	usd
CY2023Q1	us-gaap	Depreciation Depreciation	181652	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	40050000	twd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	1303287	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	10005000	twd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	325578	usd
CY2022Q4	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	667000	shares
CY2024Q1	akom	Investment Cost Ejectt Longterm InvestmentCostEjecttLongterm	-4087065	usd
CY2023Q4	akom	Investment Cost Ejectt Longterm InvestmentCostEjecttLongterm	-4261920	usd
CY2024Q1	us-gaap	Long Term Investments LongTermInvestments	4087065	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	4261920	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2023	akom	Number Of Shares Forfeited Cancelledin Shares NumberOfSharesForfeitedCancelledinShares		shares
CY2024Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	17391926	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	17406469	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4815443	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4381777	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12576483	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13024692	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	434929	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	123750	usd
CY2023Q3	akom	Ownership Percentage OwnershipPercentage	1	pure
CY2023Q3	us-gaap	Shares Issued SharesIssued	7000448	shares
CY2023Q3	us-gaap	Share Price SharePrice	2.36
CY2023Q3	akom	Acquisition Cost AcquisitionCost	11926181	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	4573819	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	4561037	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4561037	usd
CY2023	akom	Goodwill Addition GoodwillAddition	4573819	usd
CY2023	akom	Accumulated Impairment Addition AccumulatedImpairmentAddition	4561037	usd
CY2023	akom	Goodwill Addition Net GoodwillAdditionNet	12782	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	9134856	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	4561037	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4573819	usd
CY2024Q1	us-gaap	Goodwill Gross GoodwillGross	9134856	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	4561037	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4573819	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4561037	usd
CY2024Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	4561037	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4573819	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y11M19D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y7M6D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M6D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06	pure
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0382	pure
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0382	pure
CY2024Q1	akom	Lease Expense LeaseExpense	32001	usd
CY2023Q1	akom	Lease Expense LeaseExpense	33184	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	2019	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	24580	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	29982	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	8604	usd
CY2024Q1	akom	Finance Lease Amortization Of Property And Equipment FinanceLeaseAmortizationOfPropertyAndEquipment	-2700	usd
CY2023Q1	akom	Finance Lease Amortization Of Property And Equipment FinanceLeaseAmortizationOfPropertyAndEquipment	-2794	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	109	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	218	usd
CY2024Q1	akom	Total Finance Lease Cost TotalFinanceLeaseCost	2809	usd
CY2023Q1	akom	Total Finance Lease Cost TotalFinanceLeaseCost	3012	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023	akom	Weighted Average Fair Value Per Share Forfeited Cancelled Per Shares WeightedAverageFairValuePerShareForfeitedCancelledPerShares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
CY2024Q1	akom	Number Of Shares Forfeited Cancelledin Shares NumberOfSharesForfeitedCancelledinShares		shares
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	15743	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	9531	usd
CY2024	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2674	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	2706	usd
CY2024	akom	Financing Cash Outflows From Finance Lease FinancingCashOutflowsFromFinanceLease	151	usd
CY2023	akom	Financing Cash Outflows From Finance Lease FinancingCashOutflowsFromFinanceLease	218	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	345204	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	99755	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	89256	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14876	usd
CY2024Q1	akom	Totaloperating Lease Payments TotaloperatingLeasePayments	203887	usd
CY2024Q1	akom	Lessoperating Imputed Interest LessoperatingImputedInterest	-12580	usd
CY2024Q1	akom	Present Value Of Finance Lease Liabilities PresentValueOfFinanceLeaseLiabilities	191307	usd
CY2024Q1	akom	Operating Lease Liability Related Party And Others Current Portion OperatingLeaseLiabilityRelatedPartyAndOthersCurrentPortion	-90978	usd
CY2024Q1	akom	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	100329	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	9625	usd
CY2024Q1	us-gaap	Lease Income LeaseIncome	9625	usd
CY2024Q1	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	151	usd
CY2024Q1	akom	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	9474	usd
CY2024Q1	us-gaap	Net Investment In Lease Current NetInvestmentInLeaseCurrent	9474	usd
CY2021Q2	akom	Loan Agreement In The Amount LoanAgreementInTheAmount	1433177	usd
CY2021Q2	akom	Loan Agreement In The Amount LoanAgreementInTheAmount	40000000	twd
CY2021Q2	akom	Agreed Shares AgreedShares	3000000	shares
CY2024Q1	akom	Repaid Outstanding Loan RepaidOutstandingLoan	930521	usd
CY2024Q1	akom	Repaid Outstanding Loan RepaidOutstandingLoan	30000000	twd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	1500000	twd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	46978	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	48988	usd
CY2024Q1	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2024-05-21
CY2024Q1	akom	Line Of Credit Facility Commitments Fee Percentage LineOfCreditFacilityCommitmentsFeePercentage	0.097	pure
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1982	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1982	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Imputed Interest UnrecordedUnconditionalPurchaseObligationImputedInterest	24	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1958	usd
CY2024Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1958	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5168	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5168	usd
CY2023Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Imputed Interest UnrecordedUnconditionalPurchaseObligationImputedInterest	123	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	5045	usd
CY2023Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	5045	usd
CY2020Q4	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	200000	usd
CY2020Q4	akom	Interest Of Percentage InterestOfPercentage	0.075	pure
CY2024Q1	akom	Redemptions Of Debt Description RedemptionsOfDebtDescription	The Company has the option to redeem the Bonds at a redemption amount equal to the Early Redemption Amount, as defined in the Offering Memorandum, at any time on or after December 2, 2023 and prior to the Maturity Date, if the Closing Price of the Company’s Common Stock listed on the Euronext Paris for 20 trading days in any period of 30 consecutive trading days, the last day of which occurs not more than fifteen trading days prior to the date on which notice of such redemption is given, is greater than 130% of the Conversion Price on each applicable trading day or (ii) in whole or in part of the Bonds on the second anniversary of the issue date or (iii) where 90% or more in principal amount of the Bonds issued have been redeemed, converted or repurchased and cancelled.
CY2020Q4	akom	Common Stock Convertible Par Or Stated Value Per Share CommonStockConvertibleParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	13.3
CY2024Q1	akom	Total Repaid TotalRepaid	7330000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	akom	Weighted Average Fair Value Per Share Forfeited Cancelled Per Shares WeightedAverageFairValuePerShareForfeitedCancelledPerShares
CY2024Q1	akom	Principal And Interest PrincipalAndInterest	10398385	usd
CY2024Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3068385	usd
CY2024Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3253239	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	10200000	usd
CY2024Q1	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	334902	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	551845	usd
CY2024Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	2918337	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	9648155	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	216943	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	125134	usd
CY2022Q2	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	3175200	usd
CY2022Q3	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	5674000	usd
CY2022Q4	akom	Common Stock Total Subscriptions Value CommonStockTotalSubscriptionsValue	13173200	usd
CY2024Q1	us-gaap	Other Additional Capital OtherAdditionalCapital	10000000	usd
CY2024Q1	us-gaap	Convertible Debt ConvertibleDebt	30000000	usd
CY2024Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.04	pure
CY2024Q1	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	6
CY2015Q1	akom	Purchase Agreement Terms PurchaseAgreementTerms	P10Y
CY2015Q1	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	909000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2024Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2400	usd
CY2024Q1	us-gaap	Income Loss From Subsidiaries Tax Expense Benefit IncomeLossFromSubsidiariesTaxExpenseBenefit	2400	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1856347	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-642805	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1366499	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1008874	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	116696	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-140193	usd
CY2024Q1	akom	Stockbased Compensation Expense StockbasedCompensationExpense	134900	usd
CY2023Q1	akom	Stockbased Compensation Expense StockbasedCompensationExpense	11500	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18900	usd
CY2024Q1	akom	Accrued Payroll AccruedPayroll	-109600	usd
CY2023Q1	akom	Accrued Payroll AccruedPayroll	-31600	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	91252	usd
CY2023Q1	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-273276	usd
CY2024Q1	akom	Deferred Costs Gross Other DeferredCostsGrossOther	5800	usd
CY2023Q1	akom	Deferred Costs Gross Other DeferredCostsGrossOther	-14600	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2400	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16496000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14831000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3502000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3502000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1041000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	889000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	68000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	68000	usd
CY2024Q1	akom	Unrealized Exchanges Losses UnrealizedExchangesLosses	109000	usd
CY2023Q4	akom	Unrealized Exchanges Losses UnrealizedExchangesLosses	20000	usd
CY2024Q1	akom	Excess Of Tax Amortization Over Book Amortization ExcessOfTaxAmortizationOverBookAmortization	-216000	usd
CY2023Q4	akom	Excess Of Tax Amortization Over Book Amortization ExcessOfTaxAmortizationOverBookAmortization	-285000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	47000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	27000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21047000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	19052000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	21047000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19052000	usd
CY2024Q1	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1995000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	90000000	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1802373	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1802373	shares
CY2024Q1	akom	Share Based Compensation Arrangement By Sharebased Payment Award Option Nonvested Number Of Shares ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedNumberOfShares	149162	shares
CY2023	akom	Share Based Compensation Arrangement By Sharebased Payment Award Option Nonvested Number Of Shares ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionNonvestedNumberOfShares	149162	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1951535	shares
CY2023	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1951535	shares
CY2024Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P2Y
CY2024Q1	us-gaap	Other Expenses OtherExpenses	6820000	jpy
CY2022	us-gaap	Other Expenses OtherExpenses	51800	usd
CY2023Q4	akom	Sales Agreements SalesAgreements	1243247	usd
CY2024Q1	akom	Sales Agreements SalesAgreements	1192240	usd
CY2023Q3	us-gaap	Security Deposit SecurityDeposit	20000000	twd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	653168	usd
CY2024Q1	us-gaap	Security Deposit SecurityDeposit	626370	usd
CY2024Q1	us-gaap	Equipment Expense EquipmentExpense	4035624	usd
CY2023Q4	us-gaap	Equipment Expense EquipmentExpense	5333333	twd
CY2023	us-gaap	Equipment Expense EquipmentExpense	174178	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2076138	usd
CY2024Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2073448	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	59021	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	56600	usd
CY2024Q1	us-gaap	Other Borrowings OtherBorrowings	1258267	usd
CY2021	akom	Consulting Fees ConsultingFees	15120	eur
CY2021	akom	Consulting Fees ConsultingFees	17000	usd
CY2023Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	75326	usd
CY2023Q4	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	2306000	twd
CY2024Q1	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	106374	usd
CY2024Q1	us-gaap	Longterm Construction Loan Current And Noncurrent LongtermConstructionLoanCurrentAndNoncurrent	3396000	twd
CY2023Q1	akom	Purchase From Ejectt PurchaseFromEjectt	454281	usd
CY2024Q1	akom	Rental Income From Ee Sqaure Jp RentalIncomeFromEESqaureJP	-2019	usd
CY2023Q1	akom	Rental Income From Ee Sqaure Jp RentalIncomeFromEESqaureJP	-2266	usd
CY2017Q2	akom	Vest Rate Percentage VestRatePercentage	0.50	pure
CY2017Q3	us-gaap	Shares Acquired Weighted Average Discount To Net Assets Percentage SharesAcquiredWeightedAverageDiscountToNetAssetsPercentage	0.50	pure
CY2017Q4	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2018Q4	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2019Q4	akom	Aggregate Shares AggregateShares	85400	shares
CY2019Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2021Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2022Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2020Q4	akom	Vest Rate Percentage VestRatePercentage	0.25	pure
CY2019Q4	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2021Q1	akom	Independent Directors Shares IndependentDirectorsShares	4000	shares
CY2021Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2021Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	8000	shares
CY2021Q4	akom	Stock Option Aggregate Share StockOptionAggregateShare	4000	shares
CY2021Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	2000	shares
CY2022Q1	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2022Q3	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2022Q3	akom	Stock Option Aggregate Shares StockOptionAggregateShares	4000	shares
CY2022Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2022Q4	akom	Stock Option Aggregate Shares StockOptionAggregateShares	8000	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	4000	shares
CY2023Q1	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2023Q2	akom	Stock Option Aggregate Shares StockOptionAggregateShares	18750	shares
CY2023Q2	akom	Stock Option Aggregate Shares StockOptionAggregateShares	3627679	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	642374	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	54891	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001590496

Files In Submission

Name	View Source	Status
0001213900-24-047257-index-headers.html	Edgar Link	pending
0001213900-24-047257-index.html	Edgar Link	pending
0001213900-24-047257.txt	Edgar Link	pending
0001213900-24-047257-xbrl.zip	Edgar Link	pending
akom-20240331.xsd	Edgar Link	pending
ea0206891-10q_aerkomm.htm	Edgar Link	pending
ea020689101ex31-1_aerkomm.htm	Edgar Link	pending
ea020689101ex31-2_aerkomm.htm	Edgar Link	pending
ea020689101ex32-1_aerkomm.htm	Edgar Link	pending
ea020689101ex32-2_aerkomm.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
akom-20240331_pre.xml	Edgar Link	unprocessable
akom-20240331_lab.xml	Edgar Link	unprocessable
ea0206891-10q_aerkomm_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
akom-20240331_def.xml	Edgar Link	unprocessable
akom-20240331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKOM
Aerkomm Inc. Stock $akom

2024 Q1 Form 10-Q Financial Statement

#000121390024047257 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKOM Aerkomm Inc. Stock $akom

2024 Q1 Form 10-Q Financial Statement

#000121390024047257 Filed on May 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKOM
Aerkomm Inc. Stock $akom